# Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

> **NCT00525382** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 134 (actual)

## Conditions studied

- Urticaria

## Interventions

- **DRUG:** levocetirizine dihydrochloride

## Key facts

- **NCT ID:** NCT00525382
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2004-03
- **Final completion:** 2004-03
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2013-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00525382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00525382, "Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00525382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*